LEON Introduces New NANO® Platform

Unternehmen – 2026-08-12

Together with its cooperation partner leon-nanodrugs (LEON), Harro Höfliger welcomed around 100 guests to an exclusive event in Boston.

“Scale with Confidence” Captivates Industry Experts

At the end of July, Harro Höfliger and leon-nanodrugs (LEON) officially introduced the new NANO® platform to a broader professional audience for the first time during the “Scale with Confidence” event. Around 100 guests accepted the invitation to the three-hour gathering.

The event was opened by Dr. Wolfgang Hofmann (CEO, LEON) and Marco Laackmann (CSO, Harro Höfliger). Dr. Matthias Schumacher (CTO, LEON) then presented the new NANOme and NANOscreen systems. The focus subsequently shifted to personal exchange and networking, providing participants with the opportunity to discuss current developments and future application areas.

The new generation of compact machines has been designed to support the entire lifecycle of nanoparticle-based products, from early formulation development through to GMP-compliant manufacturing.

In the days following the event, the NANO® systems were also showcased at the mRNA-Based Therapeutics Summit, part of the World RNA Event Series, which was likewise held in Boston.

LEON Introduces New NANO® Platform

“Scale with Confidence” Captivates Industry Experts

Related news